Literature DB >> 15050935

Human monkeypox.

Daniel B Di Giulio1, Paul B Eckburg.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15050935      PMCID: PMC9533813          DOI: 10.1016/S1473-3099(04)00967-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   71.421


× No keyword cloud information.
Since submission of our review of human monkeypox, a final report of the 2003 US outbreak has been issued by the US Centers for Disease Control and Prevention (CDC) Office of Communication, which includes the updated and final numbers of human monkeypox cases. This report differs from the number of cases published in the most recent Morbidity and Mortality Weekly Report detailing this outbreak. The total number of human monkeypox cases has been revised to 72, of which 37 (51%) were laboratory confirmed. The total number of cases was changed from the previously reported number of 81, primarily because multiple cases met the exclusion criteria of the updated CDC case definition. The final numbers of confirmed and suspected human monkeypox cases are revised for three states; therefore figure 5 of our review should have the following changes, where the number of cases “under investigation” is followed by the number of laboratory-confirmed cases in parentheses: Wisconsin 39 (18), Illinois 13 (9), Indiana 16 (7). In addition, the median age of those infected should be 28 years, and the percent hospitalised should be 26% (in table 2 and page 18 of the text).
  2 in total

1.  Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-07-11       Impact factor: 17.586

Review 2.  Human monkeypox: an emerging zoonosis.

Authors:  Daniel B Di Giulio; Paul B Eckburg
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

  2 in total
  4 in total

Review 1.  Toward a system of microbial forensics: from sample collection to interpretation of evidence.

Authors:  Bruce Budowle; Steven E Schutzer; Michael S Ascher; Ronald M Atlas; James P Burans; Ranajit Chakraborty; John J Dunn; Claire M Fraser; David R Franz; Terrance J Leighton; Stephen A Morse; Randall S Murch; Jacques Ravel; Daniel L Rock; Thomas R Slezak; Stephan P Velsko; Anne C Walsh; Ronald A Walters
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

Review 2.  Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States.

Authors:  Susan M Bernard; Steven A Anderson
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

3.  Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses.

Authors:  Daisuke Hayasaka; Francis A Ennis; Masanori Terajima
Journal:  Virol J       Date:  2007-02-27       Impact factor: 4.099

4.  Injecting reason.

Authors:  Robert Sharpe
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 71.421

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.